UBS Group
EUCRU

UBS Group’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

UBS Group’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$3.94K Buy
2022
Q3 		– Sell
2022
Q2 		$2K Sell
2022
Q1 		$8K Buy
2021
Q4 		$2K Sell
2021
Q3 		$14K Buy
2021
Q2 		$14K Sell
2021
Q1 		$27K Buy
2020
Q4 		$19K Buy